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ABSTRACT 
Ayurveda is sciences of medicine and health practicing anciently and it possessing effective methods for the treatment of various 
diseases. Ayurveda not only offer approaches for the management of curable diseases but also encompasses knowledge of incurable 
diseases. Panchakarma is one of the therapies of ayurveda which purify body and cleans all shrotas even at cellular level. 
Panchakarma therapy involves many sub therapies such as; Navannasya which is very useful in the management of various diseases 
such as; facial paralysis which involves weakness of facial muscles resulting from temporary or permanent loss of facial nerve. The 
study was planned to measure efficacy of navannasya in the treatment of Arditroga and it was found that navannasya gives good 
results in Ardit or facial paralysis. Some patient of cured effectively after the treatment with Navannasya.  
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INTRODUCTION 
The current scenario of disciplinary life pattern, 
excessive movements with vehicles, use of wrong 
postures, lack of exercises, anxiety and strain etc. leads 
various diseases including; Pakshawadha 
(Paralysis)/Ardit (facial paralysis). Ardit (facial 
paralysis) is vatavyadhi associated with or without 
Pakshawadha commonly classified under neurological 
disorder. In modern science Ardit may be correlated with 
facial palsy involving weakness of cranial nerve or facial 
nerve. The condition involves drop angle of mouth, 
continuous salivation, problem in closing eyes and loss 
of nasolibial fold 
1-4
. 
Ayurveda the holistic approach of disease management 
generally described use of snehan-swedan, vastikarma 
and nasya for the management of vatvyadhi. According 
to Charak Nasyakarana (Navan Nasya) may offer 
beneficial effects in the specific treatment of Arditroga. 
Nasya therapy offer symptomatic relief in Ardit (facial 
paralysis) since it offers effective body purification 
especially at upper body part 
5-9
.  
Aim and Object: 
1. To observe the effect of Navannasya in the 
management of Ardita. 
2. To standardize the methodology of Navannasya. 
MATERIAL AND METHODS 
1. 20 patients of Ardita fulfilling the criteria of 
diagnosis were registered from O.P.D. of Govt. 
Asthang Ayurved College, Indore (M.P.). 
2. A specific research proforma was prepared 
incorporating all the signs & symptoms based on 
both Ayurveda and modern literature. 
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3. External massage for 5 minutes was done on 
selected patients of Arditroga with mahanarayan 
tail, after that mradu swedan was performed using 
hot water bag or nadiyantra.  
4. The patient was placed in the supine position with 
head lowered by placing a pillow below the neck 
and feet slightly raised. The eyes were covered with 
the cotton or folded cloth.  
5. The shodhannasya (by Katphalpowdar) was 
fixed as follows: 
Dhapananasya/Pradhamananasya: 
 Katphal powder-three muchyutii:  
       Dose: According to Videha the dose of Dhmapana 
Nasya is three Muchuti (3 pinch). 
 Navannasya/Snehannasya: 
      Dose:-Anutail-8 drops in each nostril. 
6. After giving nasya, patient was instructed to lie in 
the same position for 1 minute then patient was 
allowed to expel out the morbid dosha. 
7. At the end of the 21st days course of Nasya therapy 
the total effect of study was assessed. 
 
ASSESSMENT CRITERIA 
The assessment of the result was done by observing 
clinical signs and symptoms of Ardit as follows:  
1. Mukhvakrata  
2. Nasavakrata  
3. Greevavakrata 
4. NetraStabdhata 
5. Waksang 
6. NetraStabdhata  
7. Lalasrava 
8. KshawathuNigrah 
Following examinations were also included in the 
assessment criteria:  
1. Unable to close eyes  
2. Unable to whistle  
3. Unable to inflate mouth.  
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20 patients of Arditaroga were selected for the study, the 
general data of the participants mentioned in Table 1.
 
Table 1: General Data of Patients: 
S. No. Particular Specification Data of patient 
1. 
2. 
 
3. 
4. 
 
 
5. 
 
6. 
 
 
 
 
7. 
 
 
8. 
Age  
Sex 
 
Marital Status 
Economic Status 
 
 
Habitat 
 
Addiction 
 
 
 
 
Chronicity 
 
 
Diet 
Range in year  
Male 
Female 
Married 
Poor 
Middle 
Rich 
Urban 
Rural 
Tea 
Smoking 
Alcohol 
Sleeping Pills 
No Addiction  
Below 1 month 
(1-6) month 
Above 6 month 
Vegetarian 
Mixed 
30-70 
16 (80%) 
4 (20%) 
18 (90%) 
3 (15%) 
15 (75%) 
2 (10%) 
15 (75%) 
5 (25%) 
5 (25%) 
10 (50%) 
3 (15%) 
2 (10%) 
0 
12 (60%) 
8 (40%) 
0 
15 (75%) 
5 (25%) 
 
DISCUSSION  
In this clinical trial 20 patients of Ardit were treated to 
measure effect of Navannasya. Katphal powder was 
used as dhampananasya/Pradhamananasya and anutail 
was used as snehannasya.  
1. All the 20 patients of this series belonged to the age 
group of 30-70 years and most of the patients (80%) 
were male, so it can be say that the Ardiatroga is 
slightly more common in male than female. 
2. Majority of the patients (75%) were from urban 
area while 25% were from rural area. It may be 
possible due to the exposure of pollution, gases like 
carbon monoxide and hydrocarbons. 
3. In present study smokers were seen maximum while 
percentage of tea addicts and drunker were less. 
Smoking is neuro-degenerative & has atherogenic 
properties therefore may initiate pathogenesis of 
neurological disorder. 
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4. Majority of the patients (75%) was vegetarian while 
25% were taking mixed diet.  
5. 60% of the patients were suffering from the disease 
for a month while 40% patients had the chronicity 
of 1-6 months. 
6. All the patients (100%) were having mukhvakrata 
and khsawathunigrah as mentioned in Table No. 2. 
Other main symptoms were observed as follows:  
 Waksang and netrastabadhata (90%)  
 Nasavakarta (75%)  
 Vedana and lalasrav (40%)   
 Greevavakarta (20%)
  
Table 2: Percentage of Main Symptoms of Ardit amongst Participants: 
S. No. Symptoms No. of Patients % 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
MukhVakrata 
Nasavakrata 
Greevavarata 
Vedana 
Waksang 
NetraStabdhata 
Lalasrava 
KshawathuNigrah 
20 
15 
4 
8 
18 
18 
8 
20 
100 
75 
20 
40 
90 
90 
40 
100 
 
The other symptoms of Arditroga such as; problem to close eyes, to whistle and to inflate cheeks were observed in all 
patients (Table 3). 
Table 3: Some Important Observations in Patients of Ardit (Facial Paralysis): 
S. No. Observation No. of Patients % 
1. Unable to close the eyes 20 100 
2. Unable to whistle 20 100 
3. Unable to inflate cheeks 20 100 
 
Effect of Nasya therapy on symptoms of Ardit:  
At the end of therapy, vedana, lalasrav and 
kshawathunigrah were relieved completely while 
Nasavakrata 93%, waksang 83%, mukhavakrata 68%, 
Greevavakrata 67% and netra-stabhdhata relieved 58% 
(Table No. 4). Relief was observed in special 
observations such as; unable to close eyes, unable to 
whistle and unable to inflate cheeks (Table No. 5). The 
total effects of therapy as per symptoms index 
mentioned in Table 6. 
 
Table 4: Effect of Navannasya on Main Symptoms of Ardit Roga according to the Symptom Index: 
S. No. Symptoms S.I. 
B.T. 
S.I. 
A.T. 
Cured 
S.I. 
Effect in % 
1. 
2. 
3. 
4. 
MukhVakrata 
NasaVakrata 
Greevavakrata 
Vedana 
62 
28 
6 
8 
20 
2 
2 
- 
42 
26 
4 
8 
68 
93 
67 
100 
5. Waksang 36 6 30 83 
6. NetraStabdhata 48 22 26 58 
7. Lalasrava 8 - 8 100 
8. KshawathuNigrah 30 - 30 100 
B.T. = Before Treatment            A.T. = After Treatment         S.I. = Symptom Index 
 
Table 5: Effect of Navannasya on Special Observations of Ardit Roga according to Symptom Index 
S. No. Symptoms S.I. 
B.T. 
S.I. 
A.T. 
Cured 
S.I. 
Effect in % 
1. 
2. 
3. 
Unable to close the eyes 
Unable to whistle 
Unable to inflate cheeks 
52 
40 
38 
18 
4 
14 
34 
36 
24 
65 
90 
63 
B.T. = Before Treatment          A.T. = After Treatment                S.I. = Symptom Index 
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Table 6: Total Effect of Navannasya on 20 Patients of Ardit according to Symptom Index: 
Case No. S.I. B.T. S.I. A.T. Cured S.I. Effect in % 
1. 32 8 24 75 
2. 38 14 24 68 
3. 26 2 24 92 
4. 46 12 17 74 
5. 34 4 30 88 
6. 50 12 19 76 
7. 38 6 32 84 
8. 48 12 36 75 
9. 42 14 28 67 
11. 50 12 19 76 
12. 38 14 24 68 
13. 48 12 36 75 
14. 42 14 28 67 
15. 40 8 32 80 
16. 44 10 34 77 
17. 36 12 24 67 
18. 48 12 36 75 
19. 32 8 24 75 
20. 38 14 24 68 
 
Overall Effect of Navannasya in Ardit 
It was observed that 65% patients were cured and 35% 
received marked improvement. The study confirmed that 
Nasya therapy offer beneficial effects up to some extent 
in the treatment of Arditroga as shown in Table No. 7. 
CONCLUSION  
Nasya therapy offered symptomatic relief in Arditroga 
and Navannasya possess beneficial effects in all aspect 
in the management of facial paralysis/Ardit. The 
appreciable outcomes of study suggested that further 
research on large population require to established 
pharmacological action of Navannasya in facial 
paralysis/Ardit.
 
Table 7: Total Effect of Navannasya in Facial Paralysis/Ardit. 
S. No. Result No. of Patient % 
1. Cured (75-100%) 13 65 
2. Markedly improved (50-74%) 7 35 
3. Improved (25-49%) - - 
4. Stable (1-2.4%) - - 
5. Deterioration - - 
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